| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/16/2008 | US7425443 Treatment of diabetes with synthetic beta cells |
| 09/16/2008 | US7425435 Nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) protein for preparation and generation of amino acid for use in foods, cosmetics and medicines; bioremediation; terpenoid biosynthesis |
| 09/16/2008 | US7425428 Recombinant DNA construct for HIV envelope polypeptides and polypeptides produced thereby |
| 09/16/2008 | US7425424 Combining a labelled test compound with an isolated cell from the spleen, lymph node, thymus or a B-cell lymphocyte comprising a heterlogous polypeptide; determining kinase activity; drug screening, medical diagnosis; genetic engineering |
| 09/16/2008 | US7425420 Using g-protein coupled receptor to identify modulators for prevention and treatment of schizophrenia and related psychoses |
| 09/16/2008 | US7425339 for use in immunosuppressive therapy, in particular as inhibitors of cytotoxic T cell responses; for graft versus host disease/autoimmune disorders |
| 09/16/2008 | US7425338 Clostridial toxin derivatives and methods for treating pain |
| 09/16/2008 | US7425334 immunization of non-human animals to generate polyclonal antibodies against Nogo proteins, comprising administering an immunogenic protein that is free of all central nervous system myelin and recovering polyclonal antibodies from the animal |
| 09/16/2008 | US7425333 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen Phl p 7 |
| 09/16/2008 | US7425332 administering a mixture of polypeptides consisting of glutamic acid, tyrosine, alanine and lysine, that bind to antigen presenting cells, human leukocyte antigens and major histocompatibility complex molecules, for the treatment of autoimmune diseases |
| 09/16/2008 | US7425331 Protein A methods of use |
| 09/16/2008 | US7425330 Methods of inhibiting TNFα activity in the blood of a patient |
| 09/16/2008 | US7425327 Choline binding proteins for anti-pneumococcal vaccines |
| 09/16/2008 | US7425326 Degrading collagen within an atherosclerotic plaque in a chronically occluded animal tube or cavity by administering proteolytic enzyme; angioplasty |
| 09/16/2008 | US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies |
| 09/16/2008 | US7425324 Monocyte chemoattractant protein(MCP), mutants whose mucopolysaccharide binding site is eliminated by replacements, used to inhibit the migration and activation of leukocytes expressing their receptors; prevention of cancer, inflammatory, autoimmune and vascular diseases |
| 09/16/2008 | US7425317 Diagnosis, therapy of tumors, cancer |
| 09/16/2008 | US7425217 For therapy of tumor, wart, hyperproliferative cellular condition |
| 09/16/2008 | CA2505128C Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 09/16/2008 | CA2409748C Soluble ctla4 mutant molecules and uses thereof |
| 09/16/2008 | CA2387738C Process for producing a product containing antihypertensive tripeptides |
| 09/16/2008 | CA2376193C Therapeutic agent comprising a botulinum neurotoxin |
| 09/16/2008 | CA2373827C Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines |
| 09/16/2008 | CA2277757C Modified tumor necrosis factor |
| 09/16/2008 | CA2273017C Local administration device for solid or semi-solid formulations, time-release formulations for parenteral administration and their method of preparation |
| 09/16/2008 | CA2252799C Antiviral ricin-like proteins |
| 09/16/2008 | CA2239519C Specific binding members for human carcinoembryonic antigen, materials and methods |
| 09/16/2008 | CA2202470C Intracellular isoform of the interleukin-1-receptor antagonist |
| 09/16/2008 | CA2132091C Antibodies to alphavbeta3 integrin |
| 09/16/2008 | CA2120732C Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 09/16/2008 | CA2110730C Sustained-release preparation |
| 09/15/2008 | CA2624573A1 Method of obtaining vegetable proteins and/or peptides, proteins produced according to said method and/or peptides and use thereof |
| 09/12/2008 | WO2008109818A1 Treating cancer with granulocyte-macrophage colony stimulating factor |
| 09/12/2008 | WO2008109742A1 Modulation of complement system activation for treatment of bleeding-related inflammation |
| 09/12/2008 | WO2008109712A2 Nanoparticle delivery systems for membrane-integrating peptides |
| 09/12/2008 | WO2008109653A2 Peptides specific for human blood outgrowth endothelial cells |
| 09/12/2008 | WO2008109445A1 Compositions and methods for treating alzheimer's disease and dementia |
| 09/12/2008 | WO2008109433A2 Anti-angiogenic peptides |
| 09/12/2008 | WO2008109401A2 Composition and method for treating papilloma virus and equine sarcoids |
| 09/12/2008 | WO2008109397A2 Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions |
| 09/12/2008 | WO2008109385A2 Oral administration of a calcitonin |
| 09/12/2008 | WO2008109274A1 Nell-1 enhanced bone mineralization |
| 09/12/2008 | WO2008109119A2 Wnt compositions and methods of use thereof |
| 09/12/2008 | WO2008109068A2 A conjugate of insulin and vitamin b12 for oral delivery |
| 09/12/2008 | WO2008109010A1 Treating stroke and other diseases without inhibiting n-type calcium channels |
| 09/12/2008 | WO2008108927A2 Methods and compositions for stabilizing polypeptides |
| 09/12/2008 | WO2008108877A2 Specific lysis of staphylococcal pathogens by bacteriophage phi1 1 endolysin |
| 09/12/2008 | WO2008108736A1 Particles for delivery of bioactive factors |
| 09/12/2008 | WO2008108679A1 Tumor vaccine, a method for producing a tumor vaccine and a method for carrying out antitumor immunotherapy |
| 09/12/2008 | WO2008108673A2 Use of a peptide and an analgesic pharmaceutical agent |
| 09/12/2008 | WO2008108521A1 A novel use of kiaa0317 as an apostosis regulator |
| 09/12/2008 | WO2008108395A1 Process for producing osteocalcin-containing extract |
| 09/12/2008 | WO2008108386A1 Pharmaceutical composition |
| 09/12/2008 | WO2008108285A1 Peptide |
| 09/12/2008 | WO2008108284A1 Rankl production inhibitor |
| 09/12/2008 | WO2008107908A1 Compositions comprising peg- interferon alpha conjugates and raffinose as cryoprotectant |
| 09/12/2008 | WO2008107862A2 Use of ngf for the preparation of medicaments for the cure of reactive gliosis |
| 09/12/2008 | WO2008107641A1 Liposome preparation |
| 09/12/2008 | WO2008107533A2 Association of compounds inhibiting melanogenesis and use thereof in cosmetics and dermatology |
| 09/12/2008 | WO2008107446A1 Use of lhrh antagonists for the treatment of lower urinary tract symptoms, in particular overactive bladder and/or detrusor overactivity |
| 09/12/2008 | WO2008107422A1 Osteopontin for the prediction and treatment of cardiovascular diseases |
| 09/12/2008 | WO2008106896A1 Transgenic rodents having ngf beta gene mutants and its preparation methods, the preparation methods of the corresponding mutant proteins and the resulting mutant proteins |
| 09/12/2008 | WO2008106779A1 Gastrin compound for diabetes treatment |
| 09/12/2008 | WO2008106775A1 Combination treatment for diabetes using an egf receptor ligand and a gastrin compound |
| 09/12/2008 | WO2008106702A1 Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue |
| 09/12/2008 | WO2008084478A3 Anti-bacterial peptides and methods of treating diseases using same |
| 09/12/2008 | WO2008076275A3 Inhibiting collagen-induced platelet aggregation and activation with peptide variants |
| 09/12/2008 | WO2008074851A3 Method for inhibiting the expression of endogenous erythropoietin (epo) |
| 09/12/2008 | WO2008068422A3 Cosmetic use of a protein belonging to the ribonuclease family<0} |
| 09/12/2008 | WO2008063424A3 Methods of promoting cardiac repair using growth factors fused to heparin binding sequences |
| 09/12/2008 | WO2008060485A3 Diagnosing, monitoring and treating inflammation |
| 09/12/2008 | WO2008049073A3 Compositions for the treatment of inflammation in the brain and other tissues |
| 09/12/2008 | WO2008048996A9 Sequential combination therapy |
| 09/12/2008 | WO2008042421A3 Peptides derived from the c2 domain of epsilon pkc, and use thereof |
| 09/12/2008 | WO2008033518A3 Undercarboxylated/uncarboxylated osteocalcin increases beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decreases fat mass |
| 09/12/2008 | WO2008024128A3 Loop-variant pdz domains as biotherapeutics, diagnostics and research reagents |
| 09/12/2008 | WO2008019322A3 Methods of inhibiting and reducing tumor growth using human mannose-binding lectin |
| 09/12/2008 | WO2007146234A8 Solid oral dosage form containing an enhancer |
| 09/12/2008 | WO2007120912A3 Compositions and methods for suppression of amyloid plaque formation associated with neurodegenerative disorders. |
| 09/12/2008 | WO2007103134A3 Prolongation of survival of an allograft by inhibiting complement activity |
| 09/12/2008 | WO2007100668A3 Antidepressant prodrugs |
| 09/12/2008 | WO2007089945A3 Treating diseases by targeting silt3 |
| 09/12/2008 | WO2007059298B1 Chimeric immunoreceptor useful in treating human cancers |
| 09/12/2008 | WO2006121454A3 Use of mapc or progeny therefrom to populate lymphohematopoietic tissues |
| 09/12/2008 | WO2006076041A3 Pan-her antagonists and methods of use |
| 09/12/2008 | WO2005091856A8 Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses |
| 09/12/2008 | CA2680206A1 Nanoparticle delivery systems for membrane-integrating peptides |
| 09/12/2008 | CA2680161A1 Pharmaceutical composition |
| 09/12/2008 | CA2679939A1 Composition and method for treating papilloma virus and equine sarcoids |
| 09/12/2008 | CA2679937A1 Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions |
| 09/12/2008 | CA2679924A1 Milk-derived basic protein fraction for inhibiting rankl production |
| 09/12/2008 | CA2679841A1 Variant activin receptor polypeptides and uses thereof |
| 09/12/2008 | CA2679831A1 Treating stroke and other diseases without inhibiting n-type calcium channels |
| 09/12/2008 | CA2679723A1 Nell-1 enhanced bone mineralization |
| 09/12/2008 | CA2679690A1 Use of lhrh antagonists for the treatment of lower urinary tract symptoms, in particular overactive bladder and/or detrusor overactivity |
| 09/12/2008 | CA2679545A1 Osteopontin for the prediction and treatment of cardiovascular diseases |
| 09/12/2008 | CA2679452A1 Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue |
| 09/12/2008 | CA2679045A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
| 09/12/2008 | CA2678555A1 Amelioration of cellular stress response |
| 09/12/2008 | CA2675463A1 Association of compounds inhibiting melanogenesis and use thereof in cosmetics and dermatology |